Mission Viejo, California (CA) Pharmaceutical Preparations Companies

Featured companies
Robin Barr Enterprises Inc
27873 Esporlas
Mission Viejo CA 92692
(949) 855-1104
Bristol-Myers Squibb
22371 Canyon Crest Dr.
Mission Viejo CA 92692
(949) 457-2372
Mr Verns Exanthum Oil
Mission Viejo CA 92691
(949) 859-0542

Mr Verns Exanthum Oil eliminates need for overpriced drugs that drain your wallet.
Not satisfied? Select a reasonRate this pageSend feedback

Or try our search form or quick navigation by category and location

Bristol-Myers Squibb Company
22371 Canyon Crest Drive
Mission Viejo CA 92692
(949) 457-2372
Aadvantics Pharmaceuticals Inc
27800 Medical Center Road
Mission Viejo CA 92691
(949) 888-1735
Aeolus Pharmaceuticals Inc
26361 Crown Valley Parkway # 150
Mission Viejo CA 92691
(949) 481-9825
A & G Therapeutics Inc
23263 Madero # B
Mission Viejo CA 92691
(858) 699-3601
Dermatech Research LLC
Puerta Real # 320
Mission Viejo CA 92691
(866) 958-9995
Prime Q Solutions
26035 Acero # 100
Mission Viejo CA 92691
(949) 268-3680
Novartis Corp
26516 Maside
Mission Viejo CA 92692
(949) 582-7198
Whereorg has 12 results under Pharmaceutical Preparations Companies in Mission Viejo, CA.

Narrow down the browsing criteria below to see more companies.

Other locations for category Pharmaceutical Preparations


Top Stories
UBS flags buyback possibility after Second-quarter earnings beat
UBS , the world's largest wealth manager, on Tuesday signalled the possibility of resuming share buybacks later this year after generating more income than expected in the first six months and as it boosted...
Tue, Jul 21 2020
Greece calls EU recovery fund deal a 'national success'
Prime Minister Kyriakos Mitsotakis called a European Union deal on a post-pandemic recovery fund a "national success" that would allocate Greece around 72 billion euros ($82.38 billion) to help deal with...
Tue, Jul 21 2020
UBS second-quarter net profit dips as Swiss business dampens trading bonanza
UBS , the world's largest wealth manager, saw net profit drop 11% in the second quarter as higher trading activity failed to offset a pandemic-induced slump in retail and corporate banking.
Tue, Jul 21 2020